CALA vs. EVLO, CMRA, GNCA, ARDS, AMPE, CLVR, EFTR, PXMD, ATNFW, and LBPSW
Should you be buying Calithera Biosciences stock or one of its competitors? The main competitors of Calithera Biosciences include Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Ampio Pharmaceuticals (AMPE), Clever Leaves (CLVR), eFFECTOR Therapeutics (EFTR), PaxMedica (PXMD), 180 Life Sciences (ATNFW), and 4D pharma (LBPSW). These companies are all part of the "pharmaceutical products" industry.
Calithera Biosciences vs.
Evelo Biosciences (NASDAQ:EVLO) and Calithera Biosciences (NASDAQ:CALA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, community ranking, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.
Evelo Biosciences has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500. Comparatively, Calithera Biosciences has a beta of -0.48, suggesting that its stock price is 148% less volatile than the S&P 500.
In the previous week, Evelo Biosciences had 1 more articles in the media than Calithera Biosciences. MarketBeat recorded 2 mentions for Evelo Biosciences and 1 mentions for Calithera Biosciences. Evelo Biosciences' average media sentiment score of 0.32 beat Calithera Biosciences' score of 0.00 indicating that Evelo Biosciences is being referred to more favorably in the media.
Calithera Biosciences received 171 more outperform votes than Evelo Biosciences when rated by MarketBeat users. However, 60.50% of users gave Evelo Biosciences an outperform vote while only 56.09% of users gave Calithera Biosciences an outperform vote.
0.3% of Evelo Biosciences shares are held by institutional investors. 1.0% of Evelo Biosciences shares are held by insiders. Comparatively, 6.6% of Calithera Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
Evelo Biosciences beats Calithera Biosciences on 5 of the 8 factors compared between the two stocks.
Get Calithera Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Calithera Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:CALA) was last updated on 2/22/2025 by MarketBeat.com Staff
